After an MRI suggests a glioma, the next question is often: "Why can't they just tell from the scan? Why do I need a biopsy?" The answer is that imaging shows what a tumor looks like, but only tissue reveals what it actually is.
A definitive glioma diagnosis — the exact type, the grade, and the molecular markers that guide treatment — requires examining the tumor cells themselves. There are two main ways to obtain that tissue:
- Surgical removal (resection). Often, the best approach is surgery that both removes as much tumor as is safely possible and provides tissue for diagnosis. For many gliomas, removing the tumor is part of treatment, so diagnosis and treatment happen together.
- Biopsy. When a tumor is in a location too risky to remove, or when the priority is simply to confirm the diagnosis before planning treatment, surgeons may take a smaller sample. A stereotactic biopsy uses imaging guidance to direct a needle precisely to the tumor through a small opening, allowing a sample to be taken with great accuracy.
The choice between resection and biopsy depends on the tumor's location, size, suspected type, and your overall situation, and it's a decision your neurosurgical team makes carefully, weighing the value of removal against the risk to important brain functions.
Once tissue is obtained, a neuropathologist examines it under the microscope and orders molecular tests. This is the step that delivers your true diagnosis — and, in the modern era, it's not complete until those molecular results are back. The wait can be agonizing, but it's what allows precise, individualized treatment rather than a best guess.
A biopsy or brain surgery is a significant procedure with real risks, which your surgeon will discuss in detail. But it answers the most important question of all: exactly what is this tumor, and how should it be treated?